Background: The use of prosthetic grafts in the treatment of intermittent claudication is still a controversy. Prosthetic bypass for this usually benign condition may in some cases lead to a graft ...
Please provide your email address to receive an email when new articles are posted on . There are no definitive answers on how to treat extremely long and complex femoropopliteal lesions, but evidence ...
In patients with femoropopliteal artery disease, endovascular therapy produces fewer early complications, but surgery holds a longer-term edge in fewer amputations and better overall survival, ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ DETOUR System for treating long-segment (>25 cm) ...
Please provide your email address to receive an email when new articles are posted on . PQ Bypass Inc. announced in a press release that it has received conditional approval of its investigational ...
The recent controversy over the use of paclitaxel in the peripheral vasculature has clouded the larger debate over whether bypass is superior to endovascular therapies for the lower limbs. However, a ...
Pq Bypass Inc. received breakthrough device designation from the FDA for its Detour system, the first to permit fully percutaneous femoropopliteal bypass to treat extremely long, complex blockages in ...
IRVINE, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, ...
Femoropopliteal arterial lesions are common in patients with symptomatic peripheral arterial disease (PAD) of the lower limbs, usually presenting with intermittent claudication. Cardiovascular risk ...
Physiological Testing of Coronary Artery Stenosis by Computation of Invasive Coronary Angiography. The Wire-Free Functional Imaging (WIFI-II) Study Receive the the latest news, research, and ...
The mean age of the patients was 68 years (range, 50-88 years), 72 years for women and 67 years for men. This difference is significant (p < 0.01). There was no difference in the distribution of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results